Prolonged tamoxifen treatment increases relapse-free survival for patients with primary breast cancer expressing high levels of VEGF

Autor: Sanchez, B.C., Sundqvist, M., Fohlin, H., Spyratos, F., Nordenskjöld, B., Stål, O., Linderholm, B.K.
Zdroj: In European Journal of Cancer 2010 46(9):1580-1587
Databáze: ScienceDirect